Tracking Industry’s Lawsuits Against IRA’s Medicare Price Negotiations

Industry stakeholders have filed various lawsuits against the US government, attempting to slow down or block the implementation of a new Medicare drug price negotiation program. Pink Sheet's new chart tracks the developments.

US Federal Courthouse
Multiple pharma companies have filed suits against the Medicare drug price negotiation law. • Source: Shutterstock

The number of lawsuits that have been filed against the implementation of a new US Medicare drug price negotiation program, mandated under the Inflation Reduction Act (IRA), are mounting and Pink Sheet and our Scrip colleagues are tracking the developments.

The US Centers for Medicare and Medicaid Services (CMS) is moving ahead swiftly with building out the program, which would...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Medicare

More from Government Payers